Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 130.

Achhra, A C; Mocroft, A; Reiss, P; Sabin, C; Ryom, L; de Wit, S; Smith, C J; d'Arminio Monforte, A; Phillips, A; Weber, R; Lundgren, J; Law, M G (2016). Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. HIV Medicine, 17(4):255-268.

Kohler, P; Clemens, R; Weber, R (2015). Aufflammen des heiligen Feuers. Swiss Medical Forum, 34:758-759.

Weber, R; Huber, M; Battegay, M; Stähelin, C; Castro Batanjer, E; Calmy, A; Bregenzer, A; Bernasconi, E; Schoeni-Affolter, F; Ledergerber, B (2015). Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study. HIV Medicine, 16(3):137-151.

Brandts, Jordi; Cooper, David J; Weber, R (2015). Legitimacy, communication and leadership in the turnaround game. Management Science, 61(11):2627-2645.

Glatz, M; Juricevic, N; Altwegg, M; Bruisten, S; Komericki, P; Lautenschlager, S; Weber, R; Bosshard, P P (2014). A multicenter prospective trial to asses a new real-time polymerase chain reaction for detection of Treponema pallidum, herpes simplex-1/2 and Haemophilus ducreyi in genital, anal and oropharyngeal ulcers. Clinical Microbiology and Infection, 20(12):O1020-7.

Metzner, K J; Scherrer, A U; von Wyl, V; Böni, J; Yerly, S; Klimkait, T; Aubert, V; Furrer, H; Hirsch, H; Vernazza, P L; Cavassini, M; Calmy, A; Bernasconi, E; Weber, R; Gunthard, H F (2014). Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS, 28(15):2231-2239.

Braun, D L; Rauch, A; Durisch, N; Eberhard, N; Anagnostopoulos, A; Ledergerber, B; Metzner, K J; Böni, J; Weber, R; Fehr, J (2014). Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients. HIV Medicine, 15:625-630.

Braun, D l; Rauch, A; Durisch, N; Eberhard, N; Anagnostopoulos, A; Ledergerber, B; Metzner, K J; Böni, J; Weber, R; Fehr, J (2014). Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients. Neurobehavioral HIV Medicine, 15(10):625-630.

Young, J; Wang, Q; Fux, C A; Bernasconi, E; Furrer, H; Vernazza, P; Calmy, A; Cavassini, M; Weber, R; Battegay, M; Bucher, H C (2014). The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir. HIV Medicine, 15(8):505-510.

Hens, Thorsten (2013). Anlegerschutz und Behavioral Finance. In: Zobl, D; Giovanoli, M; Weber, R; Sethe, Rolf. Anlegerschutz im Finanzmarktrecht kontrovers diskutiert. Zürich, Basel und Genf: Schulthess Juristische Medien AG, 1-12.

Weber, R; Ruppik, M; Rickenbach, M; Spoerri, A; Furrer, H; Battegay, M; Cavassini, M; Calmy, A; Bernasconi, E; Schmid, P; Flepp, M; Kowalska, J; Ledergerber, B; Schmid, P; Schultze, D; Schöni-Affolter, F; Schüpbach, J; Speck, R; Taffé, P; Tarr, P; Telenti, A; Trkola, A; Vernazza, P; Weber, R; Yerly, S (2013). Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Medicine, 14(4):195-207.

Van Mieghem, T; Martin, A M; Weber, R; Barrea, C; Windrim, R; Hornberger, L K; Jaeggi, E; Ryan, G (2013). Fetal cardiac function in recipient twins undergoing fetoscopic laser ablation of placental anastomoses for Stage IV twin-twin transfusion syndrome. Ultrasound in Obstetrics & Gynecology, 42(1):64-69.

Weber, R; Fontana, A (2013). Status febrilis. In: Battegay, E. Siegenthalers Differenzialdiagnose: innere Krankheiten - vom Symptom zur Diagnose. Stuttgart: Georg Thieme Verlag, 111-216.

Savaria, F; Zbinden, R; Wüst, J; Burnens, A; Ledergerber, B; Weber, R; Kovari, H (2012). Antibiotikaresistenzen von E.coli in Urinproben: Prävalenzdaten dreier Laboratorien im Raum Zürich von 1985 bis 2010. Praxis, 101(9):573-579.

Worm, S W; Kamara, D A; Reiss, P; Fontas, E; De Wit, S; El-Sadr, W; D'Arminio Monforte, A; Law, M; Phillips, A; Ryom, L; Dabis, F; Weber, R; Sabin, C; Lundgren, J D (2012). Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke. Journal of Infectious Diseases, 205(4):535-539.

Staehelin, C; Keiser, O; Calmy, A; Weber, R; Elzi, L; Cavassini, M; Schmid, P; Bernasconi, E; Furrer, H (2012). Longer term clinical and virological outcome of Sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 59(1):79-85.

Huber, M; Ledergerber, B; Sauter, R; Young, J; Fehr, J; Cusini, A; Battegay, M; Calmy, A; Orasch, C; Nicca, D; Bernasconi, E; Jaccard, R; Held, L; Weber, R (2012). Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV medicine, 13(7):387-397.

Thierfelder, C; Weber, R; Elzi, L; Furrer, H; Cavassini, M; Calmy, A; Bernasconi, E; Gutmann, C; Ledergerber, B (2012). Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV Medicine, 13(2):118-126.

Murray, M; Hogg, R S; Lima, V D; May, M T; Moore, D M; Abgrall, S; Bruyand, M; D'Arminio Monforte, A; Tural, C; Gill, M J; Harris, R J; Reiss, P; Justice, A; Kirk, O; Saag, M; Smith, C J; Weber, R; Rockstroh, J; Khaykin, P; Sterne, J A C (2012). The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Medicine, 13(2):89-97.

Kocher, C; Weber, R; Friedl, A (2011). A case study of female genital tuberculosis in a Western European setting. Infection, 39(1):59-63.

Marzolini, C; Back, D; Weber, R; Furrer, H; Cavassini, M; Calmy, A; Vernazza, P; Bernasconi, E; Khoo, S; Battegay, M; Elzi, L (2011). Ageing with HIV: medication use and risk for potential drug-drug interactions. Journal of Antimicrobial Chemotherapy, 66(9):2107-2111.

Kouyos, R D; von Wyl, V; Yerly, S; Böni, J; Rieder, P; Joos, B; Taffé, P; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Rauch, A; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2011). Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clinical Infectious Diseases, 52(4):532-539.

Rieder, P; Joos, B; Scherrer, A U; Kuster, H; Braun, D; Grube, C; Niederöst, B; Leemann, C; Gianella, S; Metzner, K J; Böni, J; Weber, R; Günthard, H F (2011). Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection. Clinical Infectious Diseases, 53(12):1271-1279.

Weber, R; Stambach, D; Jaeggi, E T (2011). Diagnosis and management of common fetal arrhythmias. Journal of the Saudi Heart Association, 23(2):61-66.

Wagner, C; Preiswerk, B; Weber, R (2011). Disseminated Kaposi sarcoma in newly diagnosed HIV. Infection, 39(1):91.

von Wyl, V; Gianella, S; Fischer, M; Niederoest, B; Kuster, H; Battegay, M; Bernasconi, E; Cavassini, M; Rauch, A; Hirschel, B; Vernazza, P; Weber, R; Joos, B; Günthard, H F (2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS ONE, 6(11):e27463.

Gianella, S; von Wyl, V; Fischer, M; Niederoest, B; Battegay, M; Bernasconi, E; Cavassini, M; Rauch, A; Hirschel, B; Vernazza, P; Weber, R; Joos, B; Günthard, H F (2011). Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antiviral Therapy, 16(4):535-545.

Meier, S; Weber, R; Zbinden, R; Ruef, C; Hasse, B (2011). Extended-spectrum β-lactamase-producing gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection, 39(4):333-340.

Boillat-Blanco, Noémie; Probst, A; Da Costa, V W; Giulieri, S; Bernasconi, E; Calmy, A; Elzi, L; Rauch, A; Weber, R; Bertisch, B; Cavassini, M; Bochud, P Y (2011). Impact of a nurse vaccination program on hepatitis B immunity in a Swiss HIV clinic. Journal of Acquired Immune Deficiency Syndromes, 58(5):472-474.

Kovari, H; Weber, R (2011). Influence of antiretroviral therapy on liver disease. Current Opinion in HIV and AIDS, 6(4):272-277.

Giner, A M; Kuster, S P; Zbinden, R; Ruef, C; Ledergerber, B; Weber, R (2011). Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003-2009. Infection, 39(6):519-526.

Kaufmann, G R; Elzi, L; Weber, R; Furrer, H; Giulieri, S; Vernazza, P; Bernasconi, E; Hirschel, B; Battegay, M (2011). Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death. AIDS, 25(4):441-451.

Weber, R; Deplazes, P; Mathis, A (2011). Microsporidia. In: Versalovic, J. Manual of clinical microbiology (10th ed.). Washington, DC, US: ASM Press, 2190-2199.

Hasse, B; Ledergerber, B; Furrer, H; Battegay, M; Hirschel, B; Cavassini, M; Bertisch, B; Bernasconi, E; Weber, R (2011). Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clinical Infectious Diseases, 53(11):1130-1139.

Nobbe, S; Weber, R; Kamarashev, J; Trüeb, R M; Weibel, L (2011). Neonatal Lupus. Journal of Pediatrics, 158(2):341-341.e1.

Jaeggi, E T; Silverman, E D; Laskin, C; Kingdom, J; Golding, F; Weber, R (2011). Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses. Journal of the American College of Cardiology, 57(13):1487-1492.

Petoumenos, K; Worm, S; Reiss, P; de Wit, S; D'Arminio Monforte, A; Sabin, C; Friis-Møller, N; Weber, R; Mercie, P; Pradier, C; El-Sadr, W; Kirk, O; Lundgren, J; Law, M (2011). Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study. HIV Medicine, 12(7):412-421.

Metzner, K J; Leemann, C; Di Giallonardo, F; Grube, C; Scherrer, A U; Braun, D; Kuster, H; Weber, R; Guenthard, H F (2011). Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection. PLoS ONE, 6(7):e21734.

Arenas-Pinto, A; Grant, A; Bhaskaran, K; Copas, A; Carr, A; Worm, S W; Martinez, E; Reiss, P; Dunn, D; Weber, R; Hoy, J; Weller, I (2011). Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis. Antiviral Therapy, 16(2):219-226.

Haas, A; Zimmermann, K; Graw, F; Slack, E; Rusert, P; Ledergerber, B; Bossart, W; Weber, R; Thurnheer, M C; Battegay, M; Hirschel, B; Vernazza, P; Patuto, N; Macpherson, A J; Günthard, H F; Oxenius, A (2011). Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut, 60(11):1506-1519.

von Wyl, V; Kouyos, R D; Yerly, S; Böni, J; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Staehelin, C; Battegay, M; Vernazza, P L; Bernasconi, E; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2011). The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. Journal of Infectious Diseases, 204(7):1095-1103.

Ledergerber, B; Cavassini, M; Battegay, M; Bernasconi, E; Vernazza, P; Hirschel, B; Furrer, H; Rickenbach, M; Weber, R (2011). Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study. HIV Medicine, 12(5):279-288.

Nicoletti, J; Kuster, S; Sulser, T; Zbinden, R; Ruef, C; Ledergerber, B; Weber, R (2010). Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland. Swiss Medical Weekly, (140):w13059.

Opravil, M; Klimkait, T; Louvel, S; Wolf, E; Battegay, M; Fux, C A; Bernasconi, E; Vogel, M; Speck, R; Weber, R (2010). Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 54(1):51-58.

Gianella, S; Haeberli, L; Joos, B; Ledergerber, B; Wüthrich, R P; Weber, R; Kuster, H; Hauser, P M; Fehr, T; Mueller, N J (2010). Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transplant Infectious Disease, 12(1):1-10.

Kaiser, P; Weber, R; Rampini, S K (2010). Akute Halsschmerzen. Praxis, 99(12):687-699.

Joos, B; Rieder, P; Fischer, M; Kuster, H; Rusert, P; Trkola, A; Pillai, S K; Wong, J K; Weber, R; Günthard, H F (2010). Association between specific HIV-1 Env traits and virologic control in vivo. Infection, Genetics and Evolution, 10(3):365-372.

Murphy, T; Weber, R (2010). Confucianizing Socrates and Socratizing Confucius – On Comparing Analects 13:18 and Euthyphro. Philosophy East and West, 60(2):187-206.

Cusini, A; Rampini, S K; Bansal, V; Ledergerber, B; Kuster, S P; Ruef, C; Weber, R (2010). Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey. PLoS ONE, 5(11):e14011.

Metzner, K J; Rauch, P; von Wyl, V; Leemann, C; Grube, C; Kuster, H; Böni, J; Weber, R; Günthard, H F (2010). Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy. Journal of Infectious Diseases, 201(7):1063-1071.

Huber, M; Kovari, H; Weber, R; Meerbach, A (2010). Eine besondere Gelbsucht. Swiss Medical Forum, 10(25):450-451.

Smith, C J; Sabin, C A; Lundgren, J D; Thiebaut, R; Weber, R; Law, M; D'Arminio Monforte, A; Kirk, O; Friis-Moller, N; Phillips, A; Reiss, P; El Sadr, W; Pradier, C; Worm, S W (2010). Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS, 24(10):1537-1548.

Hasse, B; Ledergerber, B; Hirschel, B; Vernazza, P; Glass, T R; Jeannin, A; Evison, J M; Elzi, L; Cavassini, M; Bernasconi, E; Nicca, D; Weber, R (2010). Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clinical Infectious Diseases, 51(11):1314-1322.

Weber, R; Sabin, C; Reiss, P; De Wit, S; Worm, S W; Law, M; Dabis, F; D'Arminio Monforte, A; Fontas, E; El-Sadr, W; Kirk, O; Rickenbach, M; Phillips, A; Ledergerber, B; Lundgren, J (2010). HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D cohort study. Antiviral Therapy, 15(8):1077-1086.

Rieder, P; Joos, B; von Wyl, V; Kuster, H; Grube, C; Leemann, C; Böni, J; Yerly, S; Klimkait, T; Bürgisser, P; Weber, R; Fischer, M; Günthard, H F (2010). HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men. AIDS, 24(8):1177-1183.

Rotger, M; Gsponer, T; Martinez, R; Taffé, P; Elzi, L; Vernazza, P; Cavassini, M; Bernasconi, E; Hirschel, B; Furrer, H; Weber, R; Ledergerber, B; Egger, M; Telenti, A; Tarr, P E; Swiss HIV Cohort Study (2010). Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals. Clinical Infectious Diseases, 51(9):1090-1098.

Kovari, H; Ledergerber, B; Battegay, M; Rauch, A; Hirschel, B; Foguena, A K; Vernazza, P; Bernasconi, E; Mueller, N J; Weber, R (2010). Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection. Clinical Infectious Diseases, 50(4):502-511.

Ferry, T; Hirschel, B; Dang, T; Meylan, P; Delhumeau, C; Rauch, A; Weber, R; Elzi, L; Bernasconi, E; Schmid, P; Calmy, A (2010). Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia. Clinical Infectious Diseases, 50(1):115-118.

Hauser, P M; Nahimana, A; Taffé, P; Weber, R; Francioli, P; Bille, J; Rabodonirina, M (2010). Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clinical Infectious Diseases, 51(4):e28-33.

Weber, R (2010). Intestinal coccidia and microsporidia. In: Cohen, Jonatahn; Powderly, William C; Opal, Steven. Infectious Diseases. London: Mosby Elsevier, 1876-1884.

Huber, M; Weber, R; Beck, B; Schweiger, A; Grimm, F (2010). Metastasenleber mit Eosinophilie. Swiss Medical Forum, 10(40):687-688.

Kouyos, R D; von Wyl, V; Yerly, S; Böni, J; Taffé, P; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Furrer, H; Battegay, M; Vernazza, P L; Bernasconi, E; Rickenbach, M; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2010). Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. Journal of Infectious Diseases, 201(10):1488-1497.

Thurnheer, M C; Weber, R; Toutous-Trellu, L; Cavassini, M; Elzi, L; Schmid, P; Bernasconi, E; Christen, A B; Zwahlen, M; Furrer, H (2010). Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV cohort study. AIDS, 24(12):1907-1916.

Friis-Møller, N; Thiebaut, R; Reiss, P; Weber, R; Monforte, A D; De Wit, S; El-Sadr, W; Fontas, E; Worm, S W; Kirk, O; Phillips, A; Sabin, C A; Lundgren, J D; Law, M G (2010). Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. European Journal of Cardiovascular Prevention and Rehabilitation, 17(5):491-501.

Marzolini, C; Elzi, L; Gibbons, S; Weber, R; Fux, C; Furrer, H; Chave, J P; Cavassini, M; Bernasconi, E; Calmy, A; Vernazza, P; Khoo, S; Ledergerber, B; Back, D; Battegay, M (2010). Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antiviral Therapy, 15(3):413-423.

Schmid, A; Gianella, S; von Wyl, V; Metzner, K J; Scherrer, A U; Niederöst, B; Althaus, C F; Rieder, P; Grube, C; Joos, B; Weber, R; Fischer, M; Günthard, H F (2010). Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection. PLoS ONE, 5(10):e13310.

Znoj, H J; Messerli-Burgy, N; Tschopp, S; Weber, R; Christen, L; Christen, S; Grawe, K (2010). Psychotherapeutic process of cognitive-behavioral intervention in HIV-infected persons: Results from a controlled, randomized prospective clinical trial. Psychotherapy Research, 20(2):203-213.

Bucher, H C; Rickenbach, M; Young, J; Glass, T R; Vallet, Y; Bernasconi, E; Cavassini, M; Fux, C; Schiffer, V; Vernazza, P; Weber, R; Battegay, M (2010). Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy, 15(1):31-40.

Kovari, H; Ledergerber, B; Weber, R (2010). Reply to Chang and Garcia-Pagan. Clinical Infectious Diseases, 50(1):128-129.

Barden, G; Weber, R (2010). Rhetorics of authority: Leviticus and the Analects compared. Asiatische Studien / Études Asiatiques, 64(1):173-240.

Worm, S W; Sabin, C; Weber, R; Reiss, P; El-Sadr, W; Dabis, F; De Wit, S; Law, M; D'Arminio Monforte, A; Friis-Møller, N; Kirk, O; Fontas, E; Weller, I; Phillips, A; Lundgren, J (2010). Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. Journal of Infectious Diseases, 201(3):318-330.

Kuster, S P; Hasse, B; Huebner, V; Bansal, V; Zbinden, R; Ruef, C; Ledergerber, B; Weber, R (2010). Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection, 38(1):33-40.

Fehr, J S; Bloemberg, G V; Ritter, C; Hombach, M; Lüscher, T F; Weber, R; Keller, P M (2010). Septicemia caused by tick-borne bacterial pathogen Candidatus Neoehrlichia mikurensis. Emerging Infectious Diseases, 16(7):1127-1129.

Kovari, H; Ledergerber, B; Weber, R (2010). Should HIV-infected patients with unexplained chronic liver enzyme elevations be tested for hepatitis E virus? Letter Reply. Clinical Infectious Diseases, 50(11):1546-1547.

Elzi, L; Marzolini, C; Furrer, H; Ledergerber, B; Cavassini, M; Hirschel, B; Vernazza, P; Bernasconi, E; Weber, R; Battegay, M (2010). Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Archives of Internal Medicine, 170(1):57-65.

Flammer, A J; Vo, N T T; Ledergerber, B; Hermann, F; Gämperli, A; Huttner, A; Evison, J; Baumgartner, I; Cavassini, M; Hayoz, D; Quitzau, K; Hersberger, M; Sudano, I; Ruschitzka, F; Lüscher, T F; Noll, G; Weber, R (2009). Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomized controlled trial. Heart, 95(5):385-390.

Kovari, H; Ledergerber, B; Peter, U; Flepp, M; Jost, J; Schmid, P; Calmy, A; Mueller, N J; Muellhaupt, B; Weber, R (2009). Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clinical Infectious Diseases, 49(4):626-635.

Rotger, M; Bayard, C; Taffé, P; Martinez, R; Cavassini, M; Bernasconi, E; Battegay, M; Hirschel, B; Furrer, H; Witteck, A; Weber, R; Ledergerber, B; Telenti, A; Tarr, P E (2009). Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study. Circulation: Cardiovascular Genetics, 2(6):621-628.

Georgi, A; Schneemann, M; Tintelnot, K; Calligaris-Maibach, R C; Meyer, S; Weber, R; Bosshard, P P (2009). Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure. Infection, 37(4):370-373.

Worm, S W; De Wit, S; Weber, R; Sabin, C A; Reiss, P; El-Sadr, W; Monforte, A D; Kirk, O; Fontas, E; Dabis, F; Law, M G; Lundgren, J D; Friis-Møller, N (2009). Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation, 119(6):805-811.

Elzi, L; Kaufmann, G; Weber, R; Fux, C A; Cavassini, M; Hirschel, B; Vernazza, P; Bernasconi, E; Battegay, M (2009). Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals. HIV Clinical Trials, 10(4):207-214.

Sieber, M; Dillier, S; Stäuble, S; Weber, R (2009). Erfassung (Screening) und Kurzintervention bei Spitalpatienten mit Alkoholproblemen. Swiss Medical Forum, 47(9):859-861.

Haubitz, S; Saur, M; Weber, R (2009). Fieber bei Reiserückkehrern : Praktische Ratschläge für einen effizienten Abklärungsgang. Praxis, 98(6):303-311.

Ballif, M; Ledergerber, B; Battegay, M; Cavassini, M; Bernasconi, E; Schmid, P; Hirschel, B; Furrer, H; Rickenbach, M; Opravil, M; Weber, R (2009). Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007. PLoS ONE, 4(12):e8275.

Diener, H C; Hartung, H P; Bien, C G; Hacke, W; Ringelstein, E B; Ludolph, A; Deuschl, G; Wiltfang, J; Weller, M; Steinhausen, K; Stemper, B; Klatt, J; Drepper, J; Griewing, B; Meier, U; Herschel, M; Hummel, K; Paar, W D; Dintsios, C M; Schade-Brittinger, C; Weber, R; Weimar, C (2009). Klinische Studien in der Neurologie in Deutschland 2008. Aktuelle Neurologie, 36(1):8-18.

Cusini, A; Günthard, H F; Weber, R; Huber, M; Kamarashev, J; Bertisch, B; Peter, S; Beck, B (2009). Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy. BMJ Case Reports:bcr0520091904.

Bellini, C; Keiser, O; Chave, J P; Evison, Jm; Fehr, J; Kaiser, L; Weber, R; Vernazza, P; Bernasconi, E; Telenti, A; Cavassini, M (2009). Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study. HIV Medicine, 10(1):12-18.

Conen, A; Fehr, J; Glass, T R; Furrer, H; Weber, R; Vernazza, P; Hirschel, B; Cavassini, M; Bernasconi, E; Bucher, H C; Battegay, M (2009). Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral Therapy, 14(3):349-357.

Weber, R; Huber, M; Rickenbach, M; Furrer, H; Elzi, L; Hirschel, B; Cavassini, M; Bernasconi, E; Schmid, P; Ledergerber, B (2009). Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Medicine, 10(7):407-416.

Kuster, S P; Ruef, C; Ledergerber, B; Hintermann, A; Deplazes, C; Neuber, L; Weber, R (2008). Quantitative antibiotic use in hospitals: Comparison of measurements, literature review, and recommendations for a standard of reporting. Infection, 36(6):549-559.

Kuster, S P; Ruef, C; Zbinden, R; Gottschalk, J; Ledergerber, B; Neuber, L; Weber, R (2008). Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay. Journal of Antimicrobial Chemotherapy, 62(6):1451-1461.

Fischer, M; Joos, B; Niederost, B; Kaiser, P; Hafner, R; von Wyl, V; Ackermann, M; Weber, R; Gunthard, H F (2008). Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy. Retrovirology, 5:107.

D'Arminio Monforte, A; Abramson, D; Pradier, C; Weber, R; Reiss, P; Bonnet, F; Kirk, O; Law, M; De Wit, S; Friis-Møller, N; Phillips, A N; Sabin, C A; Lundgren, J D (2008). HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS, 22(16):2143-2153.

Kuster, S P; Ruef, C; Bollinger, A K; Ledergerber, B; Hintermann, A; Deplazes, C; Neuber, L; Weber, R (2008). Correlation between case mix index and antibiotic use in hospitals. Journal of Antimicrobial Chemotherapy, 62(4):837-842.

Lundgren, J D; Neuhaus, J; Babiker, A; Cooper, D; Duprez, D; El-Sadr, W; Emery, S; Gordin, F; Kowalska, J; Phillips, A; Prineas, R J; Sabin, C A; Tracy, R; Weber, R; Grund, B; Neaton, J D (2008). Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. AIDS, 22(14):F17-F24.

Vo, N T T; Ledergerber, B; Keiser, O; Hirschel, B; Furrer, H; Battegay, M; Cavassini, M; Bernasconi, E; Vernazza, P; Weber, R (2008). Durability and outcome of initial antiretroviral treatments received during 2000-2005 by patients in the Swiss HIV Cohort Study. Journal of Infectious Diseases, 197(12):1685-1694.

Berger, S; Schad, T; von Wyl, V; Ehlert, Ulrike; Zellweger, C; Furrer, H; Regli, D; Ledergerber, B; Battegay, M; Weber, R; Gaab, J; Vernazza, P (2008). Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons. AIDS, 22(6):767-775.

Trkola, A; Kuster, H; Rusert, P; von Wyl, V; Leemann, C; Weber, R; Stiegler, G; Katinger, H; Joos, B; Günthard, H F (2008). In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers. Journal of Virology, 82(3):1591-1599.

Samuel, D; Weber, R; Stock, P; Duclos-Vallée, J C; Terrault, N (2008). Are HIV-infected patients candidates for liver transplantation? Journal of Hepatology, 48(5):697-707.

Khanna, N; Opravil, M; Furrer, H; Cavassini, M; Vernazza, P; Bernasconi, E; Weber, R; Hirschel, B; Battegay, M; Kaufmann, G R (2008). CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clinical Infectious Diseases, 47(8):1093-1101.

Sabin, C A; d'Arminio Monforte, A; Friis-Moller, N; Weber, R; El-Sadr, W M; Reiss, P; Kirk, O; Mercie, P; Law, M G; De Wit, S; Pradier, C; Phillips, A N; Lundgren, J D (2008). Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. Clinical Infectious Diseases, 46(7):1101-1110.

Wolbers, M; Bucher, H C; Furrer, H; Rickenbach, M; Cavassini, M; Weber, R; Schmid, P; Bernasconi, E; Hirschel, B; Battegay, M (2008). Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Medicine, 9(6):397-405.

Joos, B; Fischer, M; Kuster, H; Pillai, S K; Wong, J K; Böni, J; Hirschel, B; Weber, R; Trkola, A; Günthard, H F (2008). HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 105(43):16725-16730.

De Wit, S; Sabin, C A; Weber, R; Worm, S W; Reiss, P; Cazanave, C; El-Sadr, W; D'Arminio Monforte, A; Fontas, E; Law, M G; Friis-Møller, N; Phillips, A (2008). Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care, 31(6):1224-1229.

Weber, R; Berger, C; Balmer, C; Kretschmar, O; Bauersfeld, U; Prêtre, René; Nadal, D; Knirsch, W (2008). Interventions using foreign material to treat congenital heart disease in children increase the risk for infective endocarditis. Pediatric Infectious Disease Journal, 27(6):544-550.

Schneider, D; Nigg, C; Käser, L; Weber, R (2008). Komplizierte versus unkomplizierte Harnwegsinfektionen. Praxis, 97(17):925-934.

Rauch, A; Gaudieri, S; Evison, J; Nolan, D; Cavassini, M; Weber, R; James, I; Furrer, H; Swiss HIV Cohort Study (2008). Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study. Antiviral Therapy, 13(3):455-460.

Weber, R; Golding, F; Jaeggi, E (2008). Managing the fetus with atrioventricular block. Heart Rhythm, 5(9):1347-1349.

Huber, M; von Wyl, V; Ammann, C G; Kuster, H; Stiegler, G; Katinger, H; Weber, R; Fischer, M; Stoiber, H; Günthard, H F; Trkola, A (2008). Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked. Journal of Virology, 82(8):3834-3842.

Garbino, J; Inoubli, S; Mossdorf, E; Weber, R; Tamm, M; Soccal, P; Aubert, J D; Bridevaux, P O; Tapparel, C; Kaiser, L (2008). Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection. AIDS, 22(6):701-705.

Glass, T R; De Geest, S; Hirschel, B; Battegay, M; Furrer, H; Covassini, M; Vernazza, P L; Bernasconi, E; Rickenboch, M; Weber, R; Bucher, H C; Swiss HIV Cohort Study (2008). Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral Therapy, 13(1):77-85.

Sabin, C A; Worm, S W; Weber, R; Reiss, P; El-Sadr, W; Dabis, F; De Wit, S; Law, M; D'Arminio Monforte, A; Friis-Møller, N; Kirk, O; Pradier, C; Weller, I; Phillips, A N; Lundgren, J D; D:A:D Study Group (2008). Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet, 371(9622):1417-1426.

Joos, B; Fischer, M; Schweizer, A; Kuster, H; Böni, J; Wong, J K; Weber, R; Trkola, A; Gunthard, H F (2007). Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regions. Journal of Infectious Diseases, 196(2):313-320.

Sudano, I; Spieker, L E; Noll, G; Corti, R; Weber, R; Lüscher, T F (2006). Cardiovascular disease in HIV infection. American Heart Journal, 151(6):1147-1155.

Aceto, L; Karrer, U; Grube, Ch; Oberholzer, R; Hasse, B; Presterl, E; Böni, J; Kuster, H; Trkola, A; Weber, R; Günthard, H F (2005). Die akute HIV-1-Infektion in Zürich: 2002–2004. Praxis, 94(32):1199-1205.

Joos, B; Trkola, A; Fischer, M; Kuster, H; Rusert, P; Leemann, C; Böni, J; Oxenius, A; Price, D A; Phillips, R E; Wong, J K; Hirschel, B; Weber, R; Günthard, H F (2005). Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions. Journal of Virology, 79(14):9026-9037.

Lowy, A; Page, Julie; Jaccard, R; Ledergerber, B; Somaini, Bertino; Weber, R; Szucs, Thomas D (2005). Costs of treatment of Swiss patients with HIV on antiretroviral therapy in hospital-based and general practice-based care: a prospective cohort study. AIDS Care, 17(6):698-710.

Oxenius, A; Price, D A; Hersberger, M; Schlaepfer, E; Weber, R; Weber, M; Kundig, T M; Böni, J; Joller, H; Phillips, R E; Flepp, M; Opravil, M; Speck, R F (2004). HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load. Journal of Infectious Diseases, 189(7):1199-1208.

Haupts, S; Ledergerber, B; Böni, J; Schüpbach, J; Kronenberg, A; Opravil, M; Flepp, M; Speck, R F; Grube, C; Rentsch, K; Weber, R; Günthard, H F (2003). Impact of genotypic resistance testing on selection of salvage regimen in clinical practice. Antiviral Therapy, 8(5):443-454.

Menghini, G; Steiner, M; Weber, R; Marthaler, T; Imfeld, T (2003). Kariesprävalenz von Schülern der Stadt Winterthur: Vergleiche mit der Stadt Zürich und 16 Zürcher Landgemeinden. Schweizer Monatsschrift für Zahnmedizin SMfZ, 113(10):1062-1069.

Menghini, G; Steiner, M; Marthaler, T; Helfenstein, U; Brodowski, D; Imfeld, C; Weber, R; Imfeld, T (2003). Kariesprävalenz von Schülern in 16 Zürcher Landgemeinden in den Jahren 1992 bis 2000. Schweizer Monatsschrift für Zahnmedizin SMfZ, 113(3):267-277.

Nöstlinger, C; Page, Julie; Jaccard, R; Somaini, Bertino; Weber, R (2003). Kooperationsstrukturen in der HIV-Betreuung zwischen einem spezialisierten HIV-Zentrum und niedergelassenen Ärztinnen und Ärzten. Gesundheitswesen, 65(2):90-95.

Page, Julie; Weber, R; Somaini, Bertino; Nöstlinger, C; Donath, K; Jaccard, R (2003). Quality of generalist vs. specialty care for people with HIV on antiretroviral treatment: a prospective cohort study. HIV Medicine, 4(3):276-286.

Fischer, M; Günthard, H F; Opravil, M; Joos, B; Huber, W; Bisset, L R; Ott, P; Böni, J; Weber, R; Cone, R W (2000). Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy. AIDS Research and Human Retroviruses, 16(12):1135-1140.

Opravil, M; Cone, R W; Fischer, M; Vernazza, P L; Bassetti, S; Lorenzi, P; Bisset, L R; Ott, P; Huber, W; Knuchel, M C; Roos, Malgorzata; Lüthy, R; Weber, R (2000). Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV cohort study. Journal of Acquired Immune Deficiency Syndromes, 23(1):17-25.

Speich, R; Opravil, M; Weber, R; Hess, T; Luethy, R; Russi, E W (1992). Prospective evaluation of a prognostic score for Pneumocystis carinii pneumonia in HIV-infected patients. Chest, 102(4):1045-1048.

Weber, R; Opravil, M; Bloch, K; Speich, R; Linnenberg, H S; Kuster, H; Kägi, M; Jacquier, P; Eckert, J; Russi, E W (1990). Pneumocystis-carinii-Pneumonie bei HIV-Infektion: bessere Prognose durch frühe Diagnose. Deutsche Medizinische Wochenschrift, 115(43):1619-1623.

Opravil, M; Weber, R; Ledergerber, B; Speich, R; Siegenthaler, W; Lüthy, R (1990). Compliance and laboratory data predict relapse rate of Pneumocystis carinii pneumonia during prophylaxis with aerosol pentamidine. Klinische Wochenschrift, 68(8):397-402.

Speich, R; Weber, R; Kronauer, C M; Opravil, M; Lüthy, R; Russi, E W (1990). Prognostic score for Pneumocystis carinii pneumonia. Respiration, 57(4):259-263.

Speich, R; Weber, R; Vogt, P; Kronauer, C M; Lüthy, R; Russi, E W (1989). Aspecific and lymphocytic interstitial pneumonia in HIV infections. Swiss Medical Weekly, 119(19):601-612.

This list was generated on Tue Oct 24 12:50:05 2017 CEST.